Key Highlights:
Dr. Wendy Carter to share regulatory perspective on DAA trials: Expectations
and Current Thinking
Dr. Bill Poland and Dr. Jason Chittenden to provide hands on training on HCV
modeling and simulation
Day 2 of the event will feature hands on training with Phoenix and Trial
Simulator software
Dr. Lucy Perez from Mckinsey and Co. to share market research on HCV products
GVK Biosciences to share outcomes research on HCV products
It is our great pleasure to announce a workshop on "Quantitative Translational
Models to Accelerate Hepatitis C Drug Development". You might be interested in
attending the meeting to know
- current state of HCV market
- efficient approaches to support decision making for HCV drugs
- how modeling and simulation is helping HCV drug development
- how to do conduct these analyses
Day one of the workshop is designed for scientists and regulatory experts
involved in HCV drug development. Day two is designed for translational
research scientists interested in hands-on modeling and simulation training.
Please visit the conference website for more information:
http://ubsconnect.com/umctm2012.html
[cid:[email protected]]
Joga Gobburu, PhD, FCP, MBA | Professor | Executive Director
Center for Translational Medicine | School of Pharmacy | School of Medicine
N407, 20 N Pine, Baltimore, MD-21201
Office: (410) 706-5907 | E-mail:
[email protected]<mailto:[email protected]>
To receive latest Pharmacometrics news subscribe at
http://www.pharmacy.umaryland.edu/ctm/
To unsubscribe, send email to
[email protected]<mailto:[email protected]>
<<inline: image001.png>>